These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4876579)

  • 21. Bacteriological and clinical activity of the ampicillin-gentamicin and cephalothin-gentamicin combinations.
    Klastersky J; Cappel R; Swings G; Vandenborre L
    Am J Med Sci; 1971 Nov; 262(5):283-90. PubMed ID: 4946832
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bacteriological studies on cephalexin, an oral synthesized cephalosporin].
    Nakazawa S; Ono H; Nishino T; Kawabe H; Okubo S
    Jpn J Antibiot; 1969 Aug; 22(4):269-75. PubMed ID: 4901098
    [No Abstract]   [Full Text] [Related]  

  • 23. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
    Balsamo A; Broccali G; Lapucci A; Macchia B; Macchia F; Orlandini E; Rossello A
    J Med Chem; 1989 Jun; 32(6):1398-401. PubMed ID: 2724308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activity of carbenicillin against gram negative rods compared with that of penicillin, ampicillin and cephalosporins.
    Rosdahl N; Thomsen VF
    Chemotherapy; 1970 Mar; 15(3):137-47. PubMed ID: 4987833
    [No Abstract]   [Full Text] [Related]  

  • 26. Cephaloridine and cephalothin comparative in vitro evaluation.
    Perkins RL; Saslaw S; Hackett J
    Am J Med Sci; 1967 Mar; 253(3):293-9. PubMed ID: 4381476
    [No Abstract]   [Full Text] [Related]  

  • 27. [Microbiological studies on 7-acylamido cephalosporanic acid derivativies. 1. Structure of 7-side chain and protective effects against infections].
    Nishida M; Matsubara T; Mine Y; Yokota Y; Takano T
    Jpn J Antibiot; 1969 Apr; 22(2):144-50. PubMed ID: 4389775
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)].
    Mitsuhashi S; Yaginuma S; Ono H; Kurashige S
    Jpn J Antibiot; 1974 Apr; 27(2):152-6. PubMed ID: 4211466
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and antimicrobial activity of a dihydroampicillin and a dihydrocephalexin.
    Hashem AI; Shaban ME; Abdel-Aziz R; Abdel-Nasser G
    Arch Pharm (Weinheim); 1998 Sep; 331(9):294-6. PubMed ID: 9793485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 7-[7-(2-thienylacetamido)-cephalosporanamido]cephalosporanic and 6-[7-(2-thienylacetamido)cephalosporanamido]-penicillanic acids.
    Mazzeo P; Segnalini F
    Farmaco Sci; 1981 Nov; 36(11):916-20. PubMed ID: 7308459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terpene compounds as drugs. 8. Bacteriological and pharmacological properties of terpenyl penicillins.
    Pala G; Casadio S; Coppi G; Crescenzi E; Mantegani A
    Arzneimittelforschung; 1970 Jan; 20(1):62-8. PubMed ID: 4986283
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro activity of cefazolin against recent clinical bacterial isolates.
    Sabath LD; Wilcox C; Garner C; Finland M
    J Infect Dis; 1973 Oct; 128():Suppl:S320-6. PubMed ID: 4200651
    [No Abstract]   [Full Text] [Related]  

  • 33. 3-[(1,2,3-Thiadiazol-5-ylthio)methyl]cephalosporins.
    Lewis GS; Nelson PH
    J Med Chem; 1979 Oct; 22(10):1214-8. PubMed ID: 117106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusidic acid derivatives. I. Relationship between structure and antibacterial activity.
    Godtfredsen WO; Von Daehne W; Tybring L; Vangedal S
    J Med Chem; 1966 Jan; 9(1):15-22. PubMed ID: 4959882
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experience with parenteral ampicillin preparation (Pentrex 'Banyu')].
    Kimura Y; Adachi K; Miyata K
    Jpn J Antibiot; 1972 Apr; 25(2):61-4. PubMed ID: 4627211
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combined experimental use of polysynthetic penicillins].
    Petrova MA; Berezina EK; Chavdarova VB; Navashin SM
    Antibiotiki; 1970 Feb; 15(2):112-6. PubMed ID: 4910121
    [No Abstract]   [Full Text] [Related]  

  • 37. The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1974 Jun; 55(3):245-50. PubMed ID: 4607731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ampicillin and combination penicillins in clinical medicine (antibacterial effects)].
    Metz H
    Munch Med Wochenschr; 1972 Sep; 114(35):1515-9. PubMed ID: 4628080
    [No Abstract]   [Full Text] [Related]  

  • 39. Cephalexin: preliminary in vitro studies of a new orally administered cephalosporin and report of a case of endocarditis cured with cephalexin.
    Zabransky RJ; Gardner MA; Geraci JE
    Mayo Clin Proc; 1969 Dec; 44(12):876-85. PubMed ID: 4906646
    [No Abstract]   [Full Text] [Related]  

  • 40. Semisynthetic penicillins and cephalosporins.
    Diaconu E; Grăunte X; Dumitrescu S; Nechifor M; Hoişie S; Lupuşoru C
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(2):359-60. PubMed ID: 3187246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.